title: Availability of anti-VEGF agents for the management of advanced diabetic retinopathy in the NHS.
authors.forename: Adeela
authors.initials: A
authors.lastname: Malik
authors.forename: Hadi
authors.initials: H
authors.lastname: Zambarakji
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D003930:Diabetic Retinopathy / Q000188:drug therapy* / Q000378:metabolism; D004739:England; D006801:Humans; D013222:State Medicine; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab